Cytori Therapeutics to Webcast Second Quarter Financial Results on August 14, 2006
Posted on: Tuesday, 1 August 2006, 09:01 CDT
Cytori Therapeutics, Inc., (NASDAQ:CYTX) (Frankfurt:XMPA) announced today it will release financial results for the six months ended June 30, 2006 on Monday, August 14, 2006 at approximately 4:00 p.m. Eastern Daylight Time (EDT). The company's management will host a conference call at 4:30 p.m. (EDT) to discuss the results.
The audio webcast may be accessed under "Events & Webcasts" in the Investor Relations section of the Company's website at http://www.cytoritx.com. The webcast will be available live and by replay two hours after the call on the company's website and archived for 14 days. A telephone replay will be available for one week. To access the replay, please call +1 (303) 590-3000 (PIN: 11067643#).
About Cytori Therapeutics
Cytori Therapeutics, Inc., (NASDAQ:CYTX) (Frankfurt:XMPA) is discovering and developing proprietary cell-based therapeutics utilizing adult stem and regenerative cells derived from adipose tissue, also known as fat. The Company's investigational therapies target cardiovascular disease, spine and orthopedic conditions, gastrointestinal disorders and new approaches for aesthetic and reconstructive surgery. To facilitate processing and delivery of adipose stem and regenerative cells, Cytori has developed its proprietary Celution(TM) System to isolate and concentrate a patient's own stem and regenerative cells in about an hour. This system will dramatically improve the speed in which personalized cell-based therapies can be delivered to patients.
Source: Business Wire
Related Articles
- Cytori Therapeutics to Provide Update on Breast Reconstruction Commercialization Timeline From the 2nd Annual Stem Cell Summit
- Cytori Therapeutics Authors Review on Opportunity for Adipose Stem & Regenerative Cells in Cosmetic and Reconstructive Surgery
- Geron Presents New Data That Document Progress in Development of Therapeutic Products From Human Embryonic Stem Cells
- Cytori Therapeutics Reports Benefit of Adipose Stem and Regenerative Cells in Reconstructive Surgery From Preclinical Study
- Cytori Therapeutics Demonstrates Adipose Stem and Regenerative Cells Reduce Incidence of Arrhythmia After Heart Attacks in Preclinical Study
- Cytori Therapeutics to Participate in Stem Cell Therapy Focus Session at the BIO CEO & Investor Conference
- Cytori Therapeutics Names John Ransom, Ph.D., Vice President of Research, Regenerative Cell Technology
- Cytori Therapeutics Demonstrates Adipose Stem Cells Improve Cardiac Function and Blood Flow in Preclinical Heart Attack Study; Data Presented at American Heart Association Scientific Sessions
- Cytori Therapeutics Demonstrates Adipose Stem Cells Improve Cardiac Function in Preclinical Heart Attack Model
- Cytori Therapeutics Presents at Cell-Based Regenerative Medicine Symposium
 |
 |
User Comments (0)
RSS Feeds